 |
 |

Increasing Prevalence and Severity of Clostridium difficile Colitis in Hospitalized Patients in the United States
Rocco Ricciardi, MD, MPH;
David A. Rothenberger, MD;
Robert D. Madoff, MD;
Nancy N. Baxter, MD, PhD
Arch Surg. 2007;142(7):624-631.
Objective To evaluate changes in the epidemiological features of Clostridium difficile colitis in hospitalized patients in the United States (C difficile is a common cause of nosocomial diarrhea that has been shown to be increasing in virulence in Canada and across Europe).
Design Cohort analysis of all patients with C difficile colitis in the Nationwide Inpatient Sample.
Setting Population-based data from the Nationwide Inpatient Sample, a 20% stratified random sample of US hospital discharge abstracts from January 1, 1993, through December 31, 2003.
Patients Using standard International Classification of Diseases, Ninth Revision (ICD-9) diagnostic codes, we identified patients with C difficile colitis. We controlled for comorbid conditions by calculating the Deyo modification of the Charlson score. To determine the relationship of year of diagnosis on main outcome measures, we constructed multivariate models.
Main Outcome Measures The prevalence, case fatality, total mortality rate, and colectomy rate of C difficile colitis.
Results We found that the prevalence, case fatality, total mortality rate, and colectomy rate of C difficile colitis increased from 1993 through 2003. In our regression analysis, the year of diagnosis predicted an increase in prevalence, case fatality, total mortality rate, and colectomy rate after adjusting for potential confounders.
Conclusions The prevalence, case fatality, total mortality rate, and colectomy rate of C difficile colitis significantly increased from 1993 to 2003. These findings provide compelling evidence of the changing epidemiological features of C difficile colitis.
Author Affiliations: Departments of Surgery, University of Minnesota Medical School, Minneapolis (Drs Ricciardi, Rothenberger, Madoff, and Baxter), and St Michael's Hospital, University of Toronto, Toronto, Ontario (Dr Baxter). Dr Ricciardi is now with the Department of Colon and Rectal Surgery, Lahey Clinic, Burlington, Massachusetts.
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
RELATED ARTICLE
Increasing Prevalence and Severity of Clostridium difficile Colitis in Hospitalized Patients in the United StatesInvited Critique
Susan L. Gearhart
Arch Surg. 2007;142(7):631.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria
Citron et al.
J Antimicrob Chemother 2009;63:972-976.
ABSTRACT
| FULL TEXT
Is There a Future for Probiotics in Preventing Clostridium difficile-Associated Disease and Treatment of Recurrent Episodes?
Imhoff and Karpa
Nutr Clin Pract 2009;24:15-32.
ABSTRACT
| FULL TEXT
Clostridium difficile Infections in a Canadian Tertiary Care Hospital before and during a Regional Epidemic Associated with the BI/NAP1/027 Strain
Labbe et al.
Antimicrob. Agents Chemother. 2008;52:3180-3187.
ABSTRACT
| FULL TEXT
|